Iovance Biotherapeutics, Inc. (IOVA) at a glance

Iovance Biotherapeutics, Inc. (IOVA) is a small-cap Healthcare company. It trades at $8.01, with a -123.9% profit margin and revenue growth of 44.8%. It does not pay a dividend. Vestovix scores it 62/100 overall. Its strongest dimension is Growth (88/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$8.01

Market cap

$1.82B

P/E ratio

n/a

Dividend yield

None

Beta

0.70

52-week range

$1.76 to $9.36